Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori. (Q41008910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Richard L. Ferrero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Peter C. Junk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Philip C. Andrews

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Amita Pathak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Richard F Tabor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

9 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

16903-16913

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

Hydroxamic acids as pharmacological agents

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Marimastat: the clinical development of a matrix metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Marimastat (BB2516): current status of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Developmental toxicity of metal chelating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

The actions of bismuth in the treatment of Helicobacter pylori infections: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Inhibition of urease activity by dipeptidyl hydroxamic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Inhibition of urease activity by hydroxamic acid derivatives of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Antimicrobial activity of metals: mechanisms, molecular targets and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Recent advances in bioinorganic chemistry of bismuth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Identification of metal-associated proteins in cells by using continuous-flow gel electrophoresis and inductively coupled plasma mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Helicobacter pylori infection and current clinical areas of contention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Siderophores: Structure and Function of Microbial Iron Transport Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Towards a structural understanding of the anti-ulcer and anti-gastritis drug bismuth subsalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Susceptibility of clinical isolates of campylobacter pylori to 24 antimicrobial and anti-ulcer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

In vitro selection of resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Pentavalent organobismuth reagents. Part vi. Comparative migratory aptitudes of aryl groups in the arylation of phenols and enols by pentavalent bismuth reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

21 January 2018

A short history of SHELX

1 reference

https://api.crossref.org/works/10.1039%2FC5DT02259B

21 January 2018

Identifiers

DOI

10.1039/C5DT02259B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26352159%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference